DB17254InvestigationalProtein Based Therapies
Pacanalotamab: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on T-cell surface glycoprotein CD3 epsilon chain, Tumor necrosis factor receptor superfamily member 17, and T-cell surface glycoprotein CD3
- Also known as
- Bispecific t-cell engager antibody with a single chain fc moiety that binds to b cell maturation antigen surface receptor and cd3
- Code names
- AMG-420 · BI-836909
Resolves to
Compound
Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with Pacanalotamab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account